Bringing the proteome into focus with single-molecule proteome and proteoform analysis

Monday, June 30, 2025 at 17:00 BST / 18:00 CEST / 12:00 EDT / 09:00 PDT

To date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds the promise to achieve improved dynamic range, reproducibility, and sensitivity in addition to enabling high-resolution evaluation of the distinct proteoforms created when protein isoforms are altered with specific combinations of post-translational modifications.

In this webinar, our experts will discuss how scalable, single-molecule protein analysis is transforming the field of proteomics, with a focus on its application in neurodegenerative disease research. Learn how researchers are now able to measure up to 2,048 tau proteoforms across model systems of Alzheimer’s disease and other tauopathies, providing unprecedented insights into disease mechanisms and biomarker discovery.

Key learning objectives

• Discover the benefits of scalable, single-molecule protein analysis.
• Explore the impact of measuring up to 2,048 tau proteoforms across model systems of Alzheimer’s disease and other tauopathies.

Who should attend?

• Researchers interested in novel proteomic techniques for broadscale proteome analysis.
• Researchers interested in exploring how protein isoforms and post-translational modifications combine to create distinct proteoforms with unique impacts, including those that impact tau and Alzheimer’s disease.
• Academic, biotech, and pharmaceutical professionals.

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.